Print

Treating Metastatic Pancreatic, Colorectal, Gastroesophageal, or Biliary Cancer with Liposomal Irinotecan, Fluorouracil, Leucovorin Calcium, and Rucaparib

https://www.facingourrisk.org/research-clinical-trials/study/133/treating-metastatic-pancreatic-colorectal-gastroesophageal-or-biliary-cancer-with-chemotherapy-and-rucaparib

Clinicaltrials.gov identifier:
NCT03337087 (https://clinicaltrials.gov/show/NCT03337087)

Metastatic colorectal, pancreatic, gastroesophageal or biliary tract cancer

Study Contact Information:

For additional information, please contact the coordinating center at Mayo Clinic by phone: 855-776-0015

Principal Investigator: Tanios S. Bekaii-Saab

About the Study

This study is focused on patients with pancreatic, colorectal, gastroesophageal, or biliary (bile duct) cancer that has spread to other places in the body (metastasized). NOTE: This study is no longer enrolling patients.

This Study is Open To:

NOTE: This study is no longer enrolling patients.

This Study is Not Open To:

NOTE: This study is no longer enrolling patients.

About FORCE

FORCE is a national nonprofit organization, established in 1999. Our mission is to improve the lives of individuals and families affected by adult hereditary cancers.